Martinez-Delgado B
Human Genetics Group, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain.
Hematol Oncol. 2006 Sep;24(3):113-9. doi: 10.1002/hon.781.
Expression profiling using DNA microarrays has been very helpful to improve our knowledge of the pathobiology of many tumour types, including lymphomas. Peripheral T-cell lymphomas (PTCL) constitute an heterogeneous group of tumours with different morphologic, immunophenotypic, and clinical characteristics. Their complexity and their low frequency in the western countries have made difficult the identification of molecular events responsible of the development of these tumours. The first studies on expression profiling of PTCL have also revealed heterogeneity at this level, mainly regarding the PTCL NOS subgroup. Different molecular subgroups within PTCL unspecified have been identified associated to different expression profiles. However, the clinical significance of this molecular sub-classification remains to be probed in studies involving larger number of samples. In addition, the expression level of NF-kB pathway genes allowed to differentiate two PTCL subgroups, and this difference could have clinical interest. In general, PTCL expression profiles are difficult to interpret due to the significant proportion of other infiltrating cells accompanying the tumour. However, microarrays are being a helpful tool in the initial task of dissecting the PTCL expression profile.
使用DNA微阵列进行表达谱分析对于增进我们对包括淋巴瘤在内的多种肿瘤类型的病理生物学的了解非常有帮助。外周T细胞淋巴瘤(PTCL)是一组具有不同形态学、免疫表型和临床特征的异质性肿瘤。它们的复杂性以及在西方国家的低发病率使得确定导致这些肿瘤发生的分子事件变得困难。关于PTCL表达谱的首批研究也揭示了这一层面的异质性,主要涉及PTCL NOS亚组。已确定PTCL未特指型内不同的分子亚组与不同的表达谱相关。然而,这种分子亚分类的临床意义仍有待在涉及更多样本的研究中进行探究。此外,NF-κB信号通路基因的表达水平能够区分两个PTCL亚组,这种差异可能具有临床意义。总体而言,由于伴随肿瘤的其他浸润细胞比例较高,PTCL的表达谱难以解读。然而,微阵列在剖析PTCL表达谱的初始任务中是一个有用的工具。